Biote Corp. Files 8-K on Financials
Ticker: BTMD · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1819253
Sentiment: neutral
Topics: financial-reporting, corporate-actions
TL;DR
Biote Corp. dropped an 8-K detailing financials; former Haymaker III.
AI Summary
Biote Corp. filed an 8-K on March 12, 2024, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. Biote Corp. was formerly known as Haymaker Acquisition Corp. III until July 27, 2020.
Why It Matters
This 8-K filing provides an update on Biote Corp.'s financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- biote Corp. (company) — Registrant
- Haymaker Acquisition Corp. III (company) — Former company name
- March 12, 2024 (date) — Date of report
- July 27, 2020 (date) — Date of name change
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these financials are not provided in the excerpt.
When was biote Corp. previously known by another name?
biote Corp. was formerly known as Haymaker Acquisition Corp. III, with the name change occurring on July 27, 2020.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the company's results of operations and financial condition, as well as to file financial statements and exhibits.
Where is biote Corp. headquartered?
biote Corp. is headquartered in Irving, Texas, with its principal executive offices located at 1875 W. Walnut Hill Ln #100, Irving, Texas 75038.
What is the SEC file number for biote Corp.?
The SEC file number for biote Corp. is 001-40128.
Filing Stats: 534 words · 2 min read · ~2 pages · Grade level 9.3 · Accepted 2024-03-12 16:43:56
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share BTMD The Nasdaq Stock Mar
Filing Documents
- d759704d8k.htm (8-K) — 24KB
- d759704dex991.htm (EX-99.1) — 179KB
- g759704g0312054839668.jpg (GRAPHIC) — 3KB
- 0001193125-24-065961.txt ( ) — 347KB
- btmd-20240312.xsd (EX-101.SCH) — 3KB
- btmd-20240312_lab.xml (EX-101.LAB) — 18KB
- btmd-20240312_pre.xml (EX-101.PRE) — 11KB
- d759704d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated March 12, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. biote Corp. By: /s/ Teresa S. Weber Name: Teresa S. Weber Title: Chief Executive Officer Date: March 12, 2024